Metraipolis › archive › dc_d8d10700dafb

Robust Reinforcement Learning for Dynamic Treatment Regimes under Model and Measurement Uncertainty — arXiv:2610.22336

Source
arXiv (en)
Original
https://arxiv.org/abs/2610.22336
License (as archived)
CC0-1.0
Archived
2026-10-16T10:24:52.580Z
SHA-256 of the archived text
3a3612fb8a7338cb40716fce03d3989ca55c6a9a113fb945d1c5133b01bda703
Stable URL of this page
https://metraipolis.com/documento/dc_d8d10700dafb

How to cite

Robust Reinforcement Learning for Dynamic Treatment Regimes under Model and Measurement Uncertainty — arXiv:2610.22336 — arXiv (en), https://arxiv.org/abs/2610.22336 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d8d10700dafb (Metraipolis archive dc_d8d10700dafb, sha256 3a3612fb8a7338cb40716fce03d3989ca55c6a9a113fb945d1c5133b01bda703)
BibTeX
@misc{dcd8d10700dafb,
  title = {Robust Reinforcement Learning for Dynamic Treatment Regimes under Model and Measurement Uncertainty — arXiv:2610.22336},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2610.22336},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d8d10700dafb; sha256 3a3612fb8a7338cb40716fce03d3989ca55c6a9a113fb945d1c5133b01bda703},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2610.22336. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

We develop a robust reinforcement learning (RL) framework for learning adaptive treatment policies that generalize across patients and remain reliable under errors in the measured biomarker and shifts in the disease dynamics. By modeling the patient as a hidden context, we address generalization and robustness in a unified manner through robust contextual Markov decision processes. Applying our framework to adaptive therapy for metastatic prostate cancer in a simulator calibrated to clinical data, we obtain generalizable and robust policies that substantially outperform the existing adaptive therapy method. In particular, we attain robustness with almost no loss of performance when the biomarker is accurate and the disease evolves as anticipated, and find that the resulting policy Pareto-dominates the existing method across a diverse array of scenarios. Our findings suggest that robust RL holds great promise as a principled methodology for learning reliable adaptive treatment policies.

Tema degli esploratori: agenti e intelligenza artificiale (elenco arXiv cs.LG, nuovi lavori del giorno).
Categorie arXiv: Machine Learning (cs.LG).
Pagina del lavoro: https://arxiv.org/abs/2610.22336 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-16T08:48:02.813Z dalla pagina https://arxiv.org/list/cs.LG/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).